For the quarter ending 2026-03-31, NXNT had $726,531 increase in cash & cash equivalents over the period.
| Cash Flow | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Net loss for the year | - | - | - | 529,704 |
| Net loss | - | 316,468 | - | - |
| Net loss for the period | -276,718 | - | -166,981 | - |
| Amortization of prepaid stock-based compensation | -41,500 | 28,250 | 19,917 | 39,708 |
| Amortization of debt discount | 0 | - | - | 20,270 |
| Accounts payable | - | - | -7,500 | -3,000 |
| Shares issued for services | -75,000 | - | - | - |
| Accrued wages payable | 51,000 | 51,000 | 51,000 | 43,500 |
| Accrued interest on debentures | -59,902 | 12,023 | 12,047 | 21,392 |
| Accounts payable and accrued liabilities | 7,500 | 10,220 | - | - |
| Loan proceeds from related party | - | - | - | 30,000 |
| Net cash used in operating activities | -23,469 | -40,494 | -91,517 | -407,834 |
| Repayment of loan from related party | - | - | - | 30,000 |
| Purchase of software | 0 | - | - | 47,500 |
| Net cash used by investing activities | 0 | - | - | 480,000 |
| Proceeds from shares issued for cash | 750,000 | 10,000 | - | 0 |
| Proceeds from convertible debentures issued for cash | 0 | 0 | 50,000 | 480,000 |
| Proceeds from officer loan | 0 | - | - | - |
| Net cash provided by financing activities | 750,000 | 10,000 | 50,000 | -47,500 |
| Net increase (decrease) in cash | 726,531 | -30,494 | -41,517 | 24,666 |
| Cash at beginning of the period | 28,459 | 58,953 | 100,470 | 75,804 |
| Cash at end of the period | 754,990 | 28,459 | 58,953 | 100,470 |
Nexscient, Inc. (NXNT)
Nexscient, Inc. (NXNT)